In the clinical trials industry, 80% of trials do not meet enrolment timelines, leading to a loss of $8 million per day. Delayed enrolment not only impacts trial timelines, but more trials are being cancelled because of it, preventing investigators from determining the safety and efficacy of what could be promising new therapies for patients…
DetailsIntroduction Financial disclosures enable the readers to evaluate the potential conflict of interest (COI) which probably builds the trust of transparency in the medical publishing’s. Importance The financial disclosures are made available to the readers either in the published article or by posting the submitted financial disclosure forms online along with the published article. It…
DetailsThe global statistics for HIV/AIDS 2017 have revealed that around 37 million people across the globe were affected by HIV, out of which 1.8 million were children. 1.8 million new cases of HIV were registered in 2017, making it about 5,000 new cases per day. Around 75% of the total people affected by HIV were…
DetailsEver since HIV/AIDS is discovered, there have been lots of rumors surrounding it. This article aims at busting those myths and presenting the fact. HIV-Human Immunodeficiency Virus attacks the immune system of human body and makes a person weaker and increases his disability to fight against diseases. This is caused by having unprotected sex with…
DetailsWhat are orphan drugs? The term orphan drug refers to any drug or biological product intended for treatment, prevention or diagnosis of a rare disease. The definition of rare disease varies across countries but typically considers the prevalence of the disease, severity and existence of alternative therapies. As per WHO, a disease is considered rare…
Details
